Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
Xylyx Bio has raised $2.5M in total funding. The most recent round was Grant. The last funding was announced in September 2024.
Xylyx Bio's investors include National Institutes of Health, National Cancer Institute, National Heart, Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, Boston Harbor Angels.
Xylyx Bio is headquartered in Brooklyn, United States.
Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
Xylyx Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xylyx Bio — Funding & Investors." VCBacked, September 16, 2024, https://www.vcbacked.co/company/xylyx-bio. Accessed July 19, 2026.
VCBacked. (2024). Xylyx Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/xylyx-bio
{{cite web |title=Xylyx Bio — Funding & Investors |url=https://www.vcbacked.co/company/xylyx-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated